Abstract
In this work we report the tuberculostatic profile of a series of 5-phenyl-1,3,4-thiadiazole-2-arylhydrazone derivatives (1a-m). The evaluation of their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv was expressed as the minimum inhibitory concentration (MIC) in μg/mL. The compounds 1g and 1h exhibited inhibitory activity of 6.25 μg/mL and 1.25 μg/mL respectively, and can be considered as a good start point for the discovery of new lead compounds in the field of multi-drug resistant tuberculosis.
Keywords: 1,3,4-thiadiazoles, Antimycobacterial activity, N-arylhydrazones, Tuberculosis
Letters in Drug Design & Discovery
Title: Antimycobacterial Profile of 5-phenyl-1,3,4-thiadiazole-2-arylhydrazone Derivatives
Volume: 7 Issue: 8
Author(s): Samir A. Carvalho, Edson F. da Silva, Maria C.S. Lourenco, Marcus V.N. de Souza and Carlos A.M. Fraga
Affiliation:
Keywords: 1,3,4-thiadiazoles, Antimycobacterial activity, N-arylhydrazones, Tuberculosis
Abstract: In this work we report the tuberculostatic profile of a series of 5-phenyl-1,3,4-thiadiazole-2-arylhydrazone derivatives (1a-m). The evaluation of their in vitro antibacterial activity against Mycobacterium tuberculosis H37Rv was expressed as the minimum inhibitory concentration (MIC) in μg/mL. The compounds 1g and 1h exhibited inhibitory activity of 6.25 μg/mL and 1.25 μg/mL respectively, and can be considered as a good start point for the discovery of new lead compounds in the field of multi-drug resistant tuberculosis.
Export Options
About this article
Cite this article as:
A. Carvalho Samir, F. da Silva Edson, C.S. Lourenco Maria, V.N. de Souza Marcus and A.M. Fraga Carlos, Antimycobacterial Profile of 5-phenyl-1,3,4-thiadiazole-2-arylhydrazone Derivatives, Letters in Drug Design & Discovery 2010; 7 (8) . https://dx.doi.org/10.2174/157018010792062768
DOI https://dx.doi.org/10.2174/157018010792062768 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pyridines and Imidazopyridines with Medicinal Significance
Current Topics in Medicinal Chemistry Synthesis of 99mTc-Rifabutin: A Potential Tuberculosis Radiodiagnostic Agent
Infectious Disorders - Drug Targets Patent Selections
Recent Patents on Anti-Infective Drug Discovery Current and Future Chemotherapy for Chagas Disease
Current Medicinal Chemistry A Systematic and Meta-Analysis Study on the Prevalence of Tuberculosis and Relative Risk Factors for Prisoners in Iran
Infectious Disorders - Drug Targets Patented Biomarkers of Peripheral Blood for the Early Detection of Cancer
Recent Patents on Biomarkers Review of the Syntheses and Activities of Some Sulfur-Containing Drugs
Current Organic Synthesis Microbial Efflux Pump Inhibition: Tactics and Strategies
Current Pharmaceutical Design Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued) Advances of Bioinformatics Applied to Development and Evaluation of Boron-Containing Compounds
Current Organic Chemistry Microwave Induced One Pot Ugi Multicomponent Reaction of Fluoroquino Lone Scaffolds: Their Biological Evaluation
Current Green Chemistry Toxicogenomics to Improve Comprehension of the Mechanisms Underlying Responses of In Vitro and In Vivo Systems to Nanomaterials: A Review
Current Genomics Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism Advances in Lipid-Based Subunit Vaccine Formulations
Current Immunology Reviews (Discontinued) Targeted Tumor Immunotherapy: Are Vaccines the Future of Cancer Treatment?
Current Drug Therapy New Insights into the Immune Response to Pneumococci
Current Respiratory Medicine Reviews Editorial
Infectious Disorders - Drug Targets Trifluoroibuprofen Inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in vivo Tumor Growth in Aggressive Prostate Cancer Models
Anti-Cancer Agents in Medicinal Chemistry An Update of the Published Reports on Biologics Use for Psoriasis and the Reimbursement Status in Asia-Pacific Region
Current Rheumatology Reviews MolDock Applied to Structure-Based Virtual Screening
Current Drug Targets